Literature DB >> 36149462

Defining the care delivery value chain and mapping the patient journey in rheumatoid arthritis.

Fiona Koster1,2, Deirisa Lopes Barreto3, Sandhya C Nair4, Marc R Kok3, Angelique E A M Weel-Koenders3,5.   

Abstract

Rheumatoid Arthritis (RA) is a chronic disease that impacts patients' quality of life. Sophisticated organization of care delivery drives quality improvement. Therefore, the study objective was establishing a validated process map of the care cycle for RA patients. Hence, increasing transparency and optimizing care delivery and identifying areas of improvement. To map the RA care cycle, the care delivery value chain (CDVC) approach was used as framework to document activities and resources systematically. A mixed method study was conducted where quantitative data on activities were collected from health records and unstructured interviews with medical staff were held. Consequently, the process map was separately validated in a consensus meeting with a delegation of the medical staff and patient advisory board. At the start of the care cycle, the focus is predominantly on defining the treat-to-target strategy and examining disease activity. Towards the monitoring phase, tapering medication and managing the disease through patient-reported outcome measures are becoming increasingly important. Although patient's functioning, quality of care and patient's evaluation of received care are monitored, reflection of CDVC and engaging patients in the evaluation process resulted in improvement actions on outcome and process level. Mapping the RA care cycle following a systematic approach, provides insight and transparency in delivered activities, involved resources and the engagement of patients and caregivers at multiple levels, contributing to a system facilitating value-based care delivery. The CDVC framework and applied methodology is recommended in other conditions. Future research will focus at assigning outcomes and costs to activities and evaluating interventions to explore patient value.
© 2022. The Author(s).

Entities:  

Keywords:  Health care delivery; Patient care episodes; Patient participation; Rheumatoid arthritis

Year:  2022        PMID: 36149462     DOI: 10.1007/s00296-022-05215-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  9 in total

1.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

2.  Redefining global health-care delivery.

Authors:  Jim Yong Kim; Paul Farmer; Michael E Porter
Journal:  Lancet       Date:  2013-05-20       Impact factor: 79.321

3.  Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Authors:  Jennifer Petkovic; Jennifer L Barton; Caroline Flurey; Niti Goel; Christie M Bartels; Cheryl Barnabe; Maarten P T de Wit; Anne Lyddiatt; Diane Lacaille; Vivian Welch; Annelies Boonen; Beverley Shea; Robin Christensen; Lara J Maxwell; Willemina Campbell; Janet Jull; Karine Toupin-April; Jasvinder A Singh; Charles H Goldsmith; Antoine G Sreih; Christoph Pohl; Catherine Hofstetter; Dorcas E Beaton; Rachelle Buchbinder; Francis Guillemin; Peter S Tugwell
Journal:  J Rheumatol       Date:  2017-02-15       Impact factor: 4.666

Review 4.  Treat-to-target in rheumatoid arthritis - are we there yet?

Authors:  Ronald van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2019-03       Impact factor: 20.543

5.  Exploring the healthcare journey of patients with rheumatoid arthritis: a mapping project - implications for practice.

Authors:  Susan Oliver; Ailsa Bosworth; Mara Airoldi; Helen Bunyan; Audrey Callum; John Dixon; Diane Home; Ivan Lax; Anne O'Brien; Anthony Redmond; Sarah Ryan; D G I Scott; Alan Steuer; Lorraine Tanner
Journal:  Musculoskeletal Care       Date:  2008-12

6.  Systematic Review and Metaanalysis of the Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis.

Authors:  Sanketh Rampes; Vishit Patel; Ailsa Bosworth; Clare Jacklin; Deepak Nagra; Mark Yates; Sam Norton; James B Galloway
Journal:  J Rheumatol       Date:  2021-05-15       Impact factor: 4.666

7.  Closing the delivery gaps in pediatric HIV care in Togo, West Africa: using the care delivery value chain framework to direct quality improvement.

Authors:  Kevin Fiori; Jennifer Schechter; Monica Dey; Sandra Braganza; Joseph Rhatigan; Spero Houndenou; Christophe Gbeleou; Emmanuel Palerbo; Elfamozo Tchangani; Andrew Lopez; Emily Bensen; Lisa R Hirschhorn
Journal:  AIDS Care       Date:  2016-03

8.  The case of value-based healthcare for people living with complex long-term conditions.

Authors:  Marie Elf; Maria Flink; Marie Nilsson; Malin Tistad; Lena von Koch; Charlotte Ytterberg
Journal:  BMC Health Serv Res       Date:  2017-01-11       Impact factor: 2.655

9.  Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.

Authors:  G Wells; J-C Becker; J Teng; M Dougados; M Schiff; J Smolen; D Aletaha; P L C M van Riel
Journal:  Ann Rheum Dis       Date:  2008-05-19       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.